Takahashi M, Hoshii Y, Kawano H, Gondo T, Ishihara T, Isobe T
Department of Clinical Laboratory Science, Yamaguchi University School of Medicine, Japan.
Virchows Arch. 1996 Dec;429(6):383-8. doi: 10.1007/BF00198444.
In systemic amyloidosis, it is essential to decide what type of amyloid protein is deposited in tissues before the therapy can be selected and the prognosis assessed in each patient. We examined tissues affected by amyloid deposition from a patient with multiple myeloma by immunohistochemistry and double labelling immunogold electron microscopy and demonstrated colocalization of kappa light chain- and beta 2-microglobulin-derived amyloids in the same tissue. beta 2-Microglobulin-derived amyloid had ultrastructurally characteristic features that distinguished it from kappa light chain-derived amyloid. This is the first report of the colocalization of two different amyloids by immunoelectron microscopy.
在系统性淀粉样变性中,在为每位患者选择治疗方法并评估预后之前,确定沉积在组织中的淀粉样蛋白类型至关重要。我们通过免疫组织化学和双标记免疫金电子显微镜检查了一名多发性骨髓瘤患者受淀粉样蛋白沉积影响的组织,并证明κ轻链和β2微球蛋白衍生的淀粉样蛋白在同一组织中共定位。β2微球蛋白衍生的淀粉样蛋白具有超微结构特征,使其与κ轻链衍生的淀粉样蛋白区分开来。这是通过免疫电子显微镜首次报道两种不同淀粉样蛋白的共定位。